1. Home
  2. NMRA vs FRST Comparison

NMRA vs FRST Comparison

Compare NMRA & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • FRST
  • Stock Information
  • Founded
  • NMRA 2019
  • FRST 2004
  • Country
  • NMRA United States
  • FRST United States
  • Employees
  • NMRA N/A
  • FRST N/A
  • Industry
  • NMRA
  • FRST Major Banks
  • Sector
  • NMRA
  • FRST Finance
  • Exchange
  • NMRA Nasdaq
  • FRST Nasdaq
  • Market Cap
  • NMRA 287.6M
  • FRST 290.5M
  • IPO Year
  • NMRA 2023
  • FRST 2006
  • Fundamental
  • Price
  • NMRA $1.28
  • FRST $10.09
  • Analyst Decision
  • NMRA Buy
  • FRST Buy
  • Analyst Count
  • NMRA 8
  • FRST 1
  • Target Price
  • NMRA $10.14
  • FRST $14.00
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • FRST 115.8K
  • Earning Date
  • NMRA 03-03-2025
  • FRST 04-24-2025
  • Dividend Yield
  • NMRA N/A
  • FRST 3.99%
  • EPS Growth
  • NMRA N/A
  • FRST N/A
  • EPS
  • NMRA N/A
  • FRST N/A
  • Revenue
  • NMRA N/A
  • FRST $107,704,000.00
  • Revenue This Year
  • NMRA N/A
  • FRST $40.41
  • Revenue Next Year
  • NMRA N/A
  • FRST $12.70
  • P/E Ratio
  • NMRA N/A
  • FRST N/A
  • Revenue Growth
  • NMRA N/A
  • FRST N/A
  • 52 Week Low
  • NMRA $1.26
  • FRST $9.52
  • 52 Week High
  • NMRA $17.19
  • FRST $13.52
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.96
  • FRST 41.64
  • Support Level
  • NMRA $1.26
  • FRST $9.62
  • Resistance Level
  • NMRA $1.48
  • FRST $10.30
  • Average True Range (ATR)
  • NMRA 0.13
  • FRST 0.38
  • MACD
  • NMRA 0.08
  • FRST -0.01
  • Stochastic Oscillator
  • NMRA 4.44
  • FRST 34.56

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, it focuses on making loans secured majorly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in a number of industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts and certificates of deposit.

Share on Social Networks: